To the Editor: Emre et al. (Dec. 9 issue) 1 report “moderate improvements” with rivastigmine in patients with dementia associated with Parkinson's disease. We believe that the small size of the effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results